agree with you , cmp has had a real bad run in the past few years, check the chart, its hit bottom at 6cents recently. R&d investment is high, they have been spending 5-7m a year for years, now they have a range of new products, excess costs have been taken out of the business, market cap only 12m. there isnt another medical devive company on the asx which has a market cap of 12m for a revenve base of around 38m and who spends 5-7m on r&d every year. turnaround stock for 06-07-08.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
0.005(1.79%) |
Mkt cap ! $54.78M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.5¢ | 28.0¢ | $1.46K | 5.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19300 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 20999 | 1 |
View Market Depth
| Last trade - 14.20pm 21/07/2025 (20 minute delay) ? |
| CMP (ASX) Chart |